Your browser doesn't support javascript.
loading
A novel approach to measuring cell-mediated lympholysis using quantitative flow and imaging cytometry.
La Muraglia, G M; O'Neil, M J; Madariaga, M L; Michel, S G; Mordecai, K S; Allan, J S; Madsen, J C; Hanekamp, I M; Preffer, F I.
Afiliación
  • La Muraglia GM; Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
  • O'Neil MJ; Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
  • Madariaga ML; Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
  • Michel SG; Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
  • Mordecai KS; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
  • Allan JS; Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA; Division of Thoracic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
  • Madsen JC; Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA; Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
  • Hanekamp IM; Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
  • Preffer FI; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA. Electronic address: preffer@helix.mgh.harvard.edu.
J Immunol Methods ; 427: 85-93, 2015 Dec.
Article en En | MEDLINE | ID: mdl-26516062
ABSTRACT
In this study, we established a novel isotope-free approach for the detection of cell-mediated lympholysis (CML) in MHC defined peripheral blood mononuclear cells (PBMCs) using multiparameter flow and imaging cytometry. CML is an established in vitro assay to detect the presence of cytotoxic effector T-lymphocytes precursors (CTLp). Current methods employed in the identification of CTLp in the context of transplantation are based upon the quantification of chromium ((51)Cr) released from target cells. In order to adapt the assay to flow cytometry, primary porcine PBMC targets were labeled with eFluor670 and incubated with major histocompatibility complex (MHC) mismatched effector cytotoxic lymphocytes (CTLs). With this method, we were able to detect target-specific lysis that was comparable to that observed with the (51)Cr-based assay. In addition, the use of quantitative cell imaging demonstrates the presence of accessory cells involved in the cytotoxic pathway. This innovative technique improves upon the standard (51)Cr release assay by eliminating the need for radioisotopes and provides enhanced characterization of the interactions between effector and target cells. This technique has wide applicability to numerous experimental and clinical models involved with effector-cell interactions.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Madre / Pruebas Inmunológicas de Citotoxicidad / Linfocitos T Citotóxicos / Citotoxicidad Inmunológica / Citometría de Flujo Límite: Animals Idioma: En Revista: J Immunol Methods Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Madre / Pruebas Inmunológicas de Citotoxicidad / Linfocitos T Citotóxicos / Citotoxicidad Inmunológica / Citometría de Flujo Límite: Animals Idioma: En Revista: J Immunol Methods Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos
...